A settlement was reached with the defendants in the lawsuit filed on behalf of certain investors of Sientra Inc (NASDAQ:SIEN) over alleged securities laws violations and a deadline to submit the settlement claim is upcoming on May 8, 2017 and NASDAQ:SIEN investors should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 04/28/2017 -- The Shareholders Foundation announces that a deadline is coming up on May 8, 2017 in the settlement reached in the securities class action lawsuit filed on behalf of investors who purchased shares of Sientra Inc (NASDAQ:SIEN) between May 14, 2015 and October 28, 2015.
Investors who purchased a significant amount of shares of Sientra Inc (NASDAQ:SIEN) between May 14, 2015 and October 28, 2015, have certain options and should contact the Shareholders Foundation by email at email@example.com or call 858-779-1554.
The settlement proof of claim form or detailed settlement notice for the settlement in the Sientra Inc (NASDAQ:SIEN) Investor Securities Class Action Lawsuit can be downloaded at: http://shareholdersfoundation.com/case/sientra-inc-nasdaq-sien-investor-securities-class-action-lawsuit-09252015
In order to submit a claim an investor has to submit the claim proof to the class action claim administrator in a timely manner. The deadline to submit the proof with the class administrator is May 8, 2017. The class action administrator for this case is Gilardi & Co LLC.
The lawsuit was originally filed in the U.S. District Court for the Central District of California over alleged violations of Federal Securities Laws by Sientra Inc in connection with certain allegedly false and misleading statements made between March 18, 2015 and September 24, 2015. According to the complaint the plaintiff alleges on behalf of purchasers of Sientra Inc (NASDAQ:SIEN) common shares between March 18, 2015 and September 24, 2015, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between March 18, 2015 and September 24, 2015 Defendants made allegedly false and/or misleading statements and/or allegedly failed to disclose that Sientra Inc's exclusive reliance on Silimed's Brazilian manufacturing facilities carried significant quality control risks, that the manufacturing processes at the Silimed Rio de Janeiro manufacturing plant were contaminated, and that as a result of the above, Sientra Inc's statements regarding quality control and other financial statements were materially false and misleading at all relevant times.
Those who purchased shares of Sientra Inc (NASDAQ: SIEN) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego